{"id":"W3207977249","doi":"10.2217/fon-2021-0753","title":"Alliance A011801 (compassHER2 RD): Postneoadjuvant T-DM1 + Tucatinib/Placebo in Patients with Residual HER2-Positive Invasive Breast Cancer","year":2021,"lang":"en","type":"article","venue":"Future Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Internal medicine; Breast cancer; Oncology; Placebo; Randomized controlled trial; Cancer; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001859296,0.00108081,0.001151024,0.0005039789,0.0003663139,0.0008323697,0.0008815226,0.001240834,0.005502533],"category_scores_gemma":[0.0008190473,0.0003737855,0.001071453,0.0005059384,0.0008522543,0.0009195173,0.0005055898,0.002210033,0.0008366411],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007919699,"about_ca_system_score_gemma":0.001483269,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007269293,"about_ca_topic_score_gemma":0.003394383,"domain_scores_codex":[0.9994861,0.0002785136,0.0000350325,0.0000807883,0.00004076378,0.00007885875],"domain_scores_gemma":[0.9994746,0.00009315504,0.0001323936,0.00004040726,0.00003101647,0.0002285164],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8872203,0.02901706,0.00185828,0.001077197,0.0006962161,0.00006625697,0.0000799788,0.0009536023,0.0102865,0.0006932502,0.002021275,0.06603006],"study_design_scores_gemma":[0.7266759,0.2650659,0.002495265,0.00006170182,0.0002929206,0.0001024822,0.00004017603,0.0004649059,0.001346724,0.000276603,0.003156781,0.00002076975],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9809977,0.00531772,0.0006964489,0.001141022,0.0004544318,0.005021019,0.00110812,0.0001099873,0.005153496],"genre_scores_gemma":[0.9813228,0.003020786,0.001793038,0.001512677,0.0003882935,0.005066659,0.001580203,0.00002294731,0.005292627],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005502533,"threshold_uncertainty_score":0.01840776,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01568102170165933,"score_gpt":0.3375341293603767,"score_spread":0.3218531076587174,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}